Annual Operating Profit
-$38.26 M
-$7.70 M-25.20%
31 December 2022
Summary:
Better Therapeutics annual operaing income is currently -$38.26 million, with the most recent change of -$7.70 million (-25.20%) on 31 December 2022. During the last 3 years, it has fallen by -$31.94 million (-505.12%). BTTX annual operating profit is now -562.77% below its all-time high of -$5.77 million, reached on 31 December 2019.BTTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$5.34 M
+$1.68 M+23.97%
30 September 2023
Summary:
Better Therapeutics quarterly operating income is currently -$5.34 million, with the most recent change of +$1.68 million (+23.97%) on 30 September 2023. BTTX quarterly operating profit is now -426.21% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$29.61 M
+$5.66 M+16.03%
30 September 2023
Summary:
Better Therapeutics TTM operating income is currently -$29.61 million, with the most recent change of +$5.66 million (+16.03%) on 30 September 2023. BTTX TTM operating profit is now -2817.54% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | -505.1% | +40.6% | -60.5% |
5 y5 years | - | - | - |
BTTX Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -505.1% | at low | at high | +55.9% | -60.5% | +29.6% |
5 y | 5 years | -562.8% | at low | -426.2% | +55.9% | -2817.5% | +29.6% |
alltime | all time | -562.8% | at low | -426.2% | +55.9% | -2817.5% | +29.6% |
Better Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$5.34 M(-24.0%) | -$29.61 M(-16.0%) |
June 2023 | - | -$7.03 M(-21.3%) | -$35.27 M(-6.8%) |
Mar 2023 | - | -$8.93 M(+7.2%) | -$37.84 M(-1.1%) |
Dec 2022 | -$38.26 M(+25.2%) | -$8.32 M(-24.3%) | -$38.26 M(-9.0%) |
Sept 2022 | - | -$11.00 M(+14.6%) | -$42.04 M(+5.0%) |
June 2022 | - | -$9.60 M(+2.7%) | -$40.04 M(+8.5%) |
Mar 2022 | - | -$9.35 M(-22.8%) | -$36.92 M(+20.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$30.56 M(+383.3%) | -$12.10 M(+34.6%) | -$30.56 M(+65.6%) |
Sept 2021 | - | -$8.99 M(+38.9%) | -$18.46 M(+95.1%) |
June 2021 | - | -$6.47 M(+116.7%) | -$9.46 M(+136.4%) |
Mar 2021 | - | -$2.99 M(+194.3%) | -$4.00 M(+294.3%) |
Dec 2020 | -$6.32 M(+9.5%) | - | - |
June 2020 | - | -$1.01 M | -$1.01 M |
Dec 2019 | -$5.77 M | - | - |
FAQ
- What is Better Therapeutics annual operaing income?
- What is the all time high annual operating profit for Better Therapeutics?
- What is Better Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Better Therapeutics?
- What is Better Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Better Therapeutics?
What is Better Therapeutics annual operaing income?
The current annual operating profit of BTTX is -$38.26 M
What is the all time high annual operating profit for Better Therapeutics?
Better Therapeutics all-time high annual operaing income is -$5.77 M
What is Better Therapeutics quarterly operating income?
The current quarterly operating profit of BTTX is -$5.34 M
What is the all time high quarterly operating profit for Better Therapeutics?
Better Therapeutics all-time high quarterly operating income is -$1.01 M
What is Better Therapeutics TTM operating income?
The current TTM operating profit of BTTX is -$29.61 M
What is the all time high TTM operating profit for Better Therapeutics?
Better Therapeutics all-time high TTM operating income is -$1.01 M